Maze Therapeutics MAZE Return on equity

Return on equity at other companies

Vertex PharmaceuticalsVRTX

23.5%—

Septerna, Inc.SEPN

-6.3%—

Stoke Therapeutics, Inc.STOK

-45.6%-66.1pp

Olema Pharmaceuticals, Inc.OLMA

-42.9%+1.3pp

Nurix Therapeutics, Inc.NRIX

-80.3%+113pp

SchrodingerSDGR

-45.7%—

FAQ

What is Maze Therapeutics's return on equity?

Maze Therapeutics (MAZE) reported return on equity of -37.3% in Q2 2026.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.